Manish Agrawal
Hematology & Oncology · Rockville, MDNPI 1275614984
Payments from drug & device makers
What this record shows
This record is dominated by education: $12 of the $12 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Gilead. That places this record below the midpoint for hematology & oncology clinicians in MD, where the typical reported total is $2,111.
Across 1 payment — averaging $11.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$12
Across 1,805 payments — averaging $768.45 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$305K
- Eisai Inc.$281K
- Merck$278K
- EMD Serono, Inc.$241K
- Pfizer$108K
- Genentech, Inc.$97K
- plus $77K from 3 others
What the payments were for
- Education$12100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 1 | $12 |
How this compares
$12 in reported general payments places this provider in the 0th percentile of 242 hematology & oncology providers in Maryland.
Other hematology & oncology in Rockville
- Nelson KalilRockville$72K
- Ralph BocciaBethesda$3.1M
- Sandra SwainBethesda$1M
- Kashif AliSilver Spring$987K
- Ani BalmanoukianBaltimore$842K
- Benjamin LevyBaltimore$578K
- Patrick FordeBaltimore$269K
- Noah HahnBaltimore$133K
- Walid El AyassSalisbury$111K
- Arun BhandariAnnapolis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.